FILE PHOTO: Former drug company executive Martin Shkreli arrives at U.S. District Court for the third day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York, U.S., August 2, 2017. REUTERS/Amr Alfiky/File Photo
NEW YORK (Reuters) - Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was found guilty of defrauding investors, was sentenced to 7 years and a $75,000 fine on Friday.
The sentence from U.S. District Judge Kiyo Matsumoto in federal court in Brooklyn, New York, was shorter than the 15 years asked for by prosecutors but much longer than the 12 to 18 months Shkreli's lawyers had sought. Shkreli did not visibly react as the sentence was announced.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
